Trial intelligence / Profile preview

Safety of 2% CHG Cloth in Healthy Volunteers

NCT02224625Phase 3Completed

Sponsor
Medline
Start
Aug 2014
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of chlorhexidine in surgical site infection (SSI) (4 arms), sponsored by Medline. Primary endpoint: Grading Scale for Visual Evaluation of Skin Condition at 35 days. Started Aug 2014; status: completed.

02

Drugs

chlorhexidine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT02224625.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02224625.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call